Company / Free Cash Flow per Share
Quest Diagnostics Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$12.03
FY2025
5-year range
$6.20 / $14.30
FY2021-FY2025
Trend
+56.1%
vs FY2024
Sector context
#16 of 148
Health Care
What the data says
Quest Diagnostics's free cash flow per share of $12.03 is higher than 89% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $3.85 in FY2017 to $14.30 in FY2023.
Based on SEC 10-K filings.
12.03 in FY2025 with a 5-year CAGR of +1.0%. Top quartile in the Health Care sector.
Declined from $14.30 to $12.03 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- +1.0%
- 10-Year CAGR
- -
Sector benchmark
+138.2% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 56.1% year-over-year.
- Ranks #16 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2023.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.03 | +56.1% |
| FY2024 | $7.70 | -46.1% |
| FY2023 | $14.30 | +22.5% |
| FY2022 | $11.67 | +88.3% |
| FY2021 | $6.20 | -45.7% |
| FY2020 | $11.42 | +73.2% |
| FY2019 | $6.59 | +13.8% |
| FY2018 | $5.80 | +50.6% |
| FY2017 | $3.85 | -12.3% |
| FY2016 | $4.39 | +59.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026